📰 Pharma Partnering News
Pharma Partnering News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Partnering. Real-time updates on events, politics, business and more.
May 27, 2024
Basel, 27 May 2024 - Roche announced today that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head...
May 27, 2024
Basel, 27 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry
May 27, 2024
Roche announced that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head of Genentech Partnering. In...
September 27, 2023
The new blockbuster paper by the St Gallen consortium reveals the efficiency pharmaceutical R&D. The majority of the approved drugs were sourced externally.
July 13, 2023
LEXINGTON, Mass.--(BUSINESS WIRE)--KSQ Therapeutics, Inc. (“KSQ”), a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics® discovery platform, announced today it has entered into a worldwide license and collaboration agreement with Roche for the development and commercia...
March 7, 2023
/PRNewswire/ -- Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today...
March 6, 2023
MUNICH, GERMANY / ACCESSWIRE / March 6, 2023 / EBD Group is thrilled to reunite on March 20-22, 2023 in Basel, Switzerland. After being held digitally for the last three years, leading executives from
March 6, 2023
EQS-News: EBD Group / Key word(s): Conference BIO-Europe Spring® 2023 is only a few weeks away 06.03.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE BIO-Europe Spring® 2023 is only a few weeks away Munich, Germany – March 6, 2023. EBD Gr...
October 11, 2022
PARIS, Oct. 11, 2022 /PRNewswire/ -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for cancer and inflammatory diseases based on its unique Mimicry platform
September 7, 2022
SOUTH SAN FRANCISCO (dpa-AFX) - Good Therapeutics Wednesday said Roche Holding AG (RHHBY) has agreed to acquire Good Therapeutics' conditionally active PD-1-regulated IL-2 Program.The deal also